R
Resistell
Biotech & Life Sciences · Muttenz, Switzerland · Founded 2017
Offers an alternative to culture-based antibiogram, the gold standard in antibiotic susceptibility testing (AST) MoreLess
Developer of an antibiotic susceptibility device designed to offer an alternative to a culture-based antibiogram. The company's device is based on the detection of movement caused by living bacterial cells to determine bacterial resistance to antibiotics, enabling patients to have proper antibiotics on time. Keywords: Pharmaceuticals and Biotechnology, Healthcare Devices / Services / Supplies, Antibiotic Resistance, Antibiotic Resistance Analysis, Antibiotic Susceptibility, Antibiotic Susceptibility Test, Antimicrobial Resistance, Antimicrobial Resistance Monitoring.
Talent graph
Resistell's talent
Source: Dealroom Talent Intelligence.
Investors
9 investors on Resistell's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Resistell has talent and traffic
team presence
Market sentiment
What the market is saying about Resistell
An AI-synthesized read of the highest-engagement posts about Resistell on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Resistell on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.